ARCA BIOPHARMA INC (ABIO) Stock Income Statement
NASDAQ:ABIO - Nasdaq - US00211Y5069 - Common Stock - Currency: USD
| TTM (2024-6-30) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Operating Expenses | 9.13M | 7.30M | 10.60M | 19.34M | 9.77M | |||
| Research and Development | 664.00K | 1.01M | 4.75M | 13.83M | 4.99M | |||
| Selling, General, and Administrative Expenses | 8.47M | 6.28M | 5.85M | 5.50M | 4.77M | |||
| Operating Income | -9.13M | -7.30M | -10.60M | -19.34M | -9.77M | |||
| Interest Income/Expense | 1.93M | 1.96M | 675.00K | 13.00K | 20.00K | |||
| Other Income/Expense | N/A | 0.00 | -5.00K | N/A | N/A | |||
| Income Before Taxes | -7.20M | -5.34M | -9.93M | -19.32M | -9.75M | |||
| Income Tax | N/A | N/A | N/A | 0.00 | -10.00K | |||
| Net Income | -7.20M | -5.34M | -9.93M | -19.32M | -9.74M | |||
| EBITDA | -9.12M | -7.28M | -10.58M | -19.32M | -9.76M | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -0.50 | -0.37 | -0.69 | -1.39 | -2.07 | |||
| Non GAAP EPS | N/A | N/A | N/A | N/A | -2.50 | |||
| Statistics | ||||||||
All data in USD